Research shows lower adverse-events for drug-eluting stents than bare metal stents in patients over 85

Published date : 04 January 2012
Article date : 04 January 2012

A report published in the Journal of the American College of Cardiology has observed lower adverse-event rates associated with drug-eluting stents (DES) versus bare metal stents (BMS) in older patients.

This national study compared the effectiveness of DES versus BMS among patients aged 85 or over undergoing percutaneous coronary intervention (PCI). 

The full report can be found here.

Compare drug-eluting stents and bare metal stents online.

Back to Listings

Share |

Find a Device

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.